Potential applications of whey proteins in the medical field

Engineering Aspects of Milk and Dairy Products

Volumn , Issue , 2016, Pages 221-252

  Rodrigues, Lígia ^a   Teixeira, José António Couto ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

INDUSTRIAL ENGINEERING;

MEDICAL FIELDS; WHEY PROTEINS;

ENGINEERING;

EID: 85051449286     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (236)

1. Adamik B, Zimecki M, Wlaszczyk A, Berezowicz P, Kubler A (1998) Lactoferrin effects on the in vitro immune response in critically ill patients. Arch Immunol Ther Exp (Warsz) 46: 169-176.
2. Aimutis WR (2004) Bioactive properties of milk proteins with particular focus on anticariogenesis. J Nutr 134: 989S-995S.
3. Al-Nabulsi AA, Holley RA (2006) Enhancing the antimicrobial effects of bovine lactoferrin against Escherichia coli O157:H7 by cation chelation, NaCl and temperature. J Appl Microbiol 100: 244-255.
4. Ammendollia MG, Pietrantoni A, Tinari A, Valenti P, Superti F (2007) Bovine lactoferrin inhibits echovirus endocytic pathway by interacting with viral structural polypeptides. Antiviral Res 73: 151-160.
5. Andersen JH, Osbakk SA, Vorland LH, Traavik T, Gutteberg TJ (2001) Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res 51: 141-149.
6. Andrews A, Harris D, Wright G, Pyle D, Asenjo JA (2000) Affinity gel electrophoresis as a predictive technique in the fractionation of transgenic sheep milk proteins by affinity aqueous two-phase partitioning. Biotechnol Lett 22: 1349-1353.
7. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864.
8. Ayers JS, Elgar DF, Pritchard M (2003) Production of an immunoglobulin enriched fraction from whey protein solutions US Patent No: 6592905. New Zealand: Massey University and New Zealand Dairy Board.
9. Baker EN (1994) Structure and reactivity of transferrins. Adv Inorg Chem 41: 389-463.
10. Baker EN, Baker HM, Kidd RD (2002) Lactoferrin and transferrin: functional variations on a common structural framework. Biochem Cell Biol 80: 27-34.
11. Barta O, Barta VD, Crisman MV, Akers RM (1991) Inhibition of lymphocyte blastogenesis by whey. Am J Vet Res 52: 247-253.
12. Baumrucker CR, Schanbacher F, Shang Y, Green MH (2006) Lactoferrin interaction with retinoid signalling: cell growth and apoptosis in mammary cells. Dom Animal End 30: 289-303.
13. Baveye S, Elass E, Mazurier J, Spik G, Legrand D (1999) Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 37: 281-286.
14. Beena A, Prasad V (1997) Effect of yoghurt and bifidus yoghurt fortified with skim milk powder, condensed whey and lactose hydrolysed condensed whey on serum cholesterol and triacylglycerol levels in rats. J Dairy Res 64: 453-457.
15. Bennett RM, Davis J (1981) Lactoferrin binding to human peripheral blood cells: an interaction with a B-enriched population of lymphocytes and a subpopulation of adherent mononuclear cells. J Immunol 127: 1211-1216.
16. Berlutti F, Schippa S, Morea C, Sarli S, Perfetto B, Donnarumma G, Valenti P (2006) Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or non-invasive Escherichia coli strains. Biochem Cell Biol 84: 351-357.
17. Bezault J, Bhimani R, Wiprovnick J, Furmanski P (1994) Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 54: 2310-2312.
18. Birgens HS, Karle H, Hansen NE, Ostergaard Kristensen L (1984) Lactoferrin receptors in normal and leukaemic human blood cells. Scand J Haematol 33: 275-280.
19. Bjorck L (1978) Antibacterial effect of the lactoperoxidase system on psychotrophic bacteria in milk. J Dairy Res 45: 109-118.
20. Bojsen A, Buesa J, Montava R, Kvistgaard AS, Kongsbak MB, Petersen TE, Heegaard CW, Rasmussen JT (2007) Inhibitory activities of bovine macromolecular whey proteins on rotavirus infections in vitro and in vivo. J Dairy Sci 90: 66-74.
21. Bonang G, Monintja HE, Sujudi, van der Waaij D (2000) Influence of breastmilk on the development of resistance to intestinal colonization in infants born at the Atma Jaya Hospital, Jakarta. Scand J Infect Dis 32: 189-196.
22. Boots J-W, Floris R (2006) Lactoperoxidase: from catalytic mechanism to practical applications. Int Dairy J 16: 1272-1276.
23. Bos C, Gaudichon C, Tome D (2000) Nutritional and physiological criteria in the assessment of milk protein quality for humans. J Am Coll Nutr 19: 191S-205S.
24. Bosselaers IM, Caessens PR, Van Boekel MS, Alink GM (1994) Differential effects of milk proteins, BSA and soy protein on 4NQO-or MNNG-induced SCEs in V79 cells. Food Chem Toxicol 32: 905-911.
25. Bounous G (2000) Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res 20: 4785-4792.
26. Bounous G, Gervais F, Amer V, Batist G, Gold P (1989) The influence of dietary whey protein on tissue glutathione and the diseases of aging. Clin Invest Med 12: 343-349.
27. Bounous G, Kongshavn PA (1982) Influence of dietary proteins on the immune system of mice. J Nutr 112: 1747-1755.
28. Bounous G, Kongshavn PA (1985) Differential effect of dietary protein type on the B-cell and T-cell immune responses in mice. J Nutr 115: 1403-1408.
29. Britigan BE, Lewis TS, Waldschmidt M, McCormick ML, Krieg AM (2001) Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J Immunol 167:2921-2928.
30. Brock JH (1980) Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant. Arch Dis Child 55: 417-421.
31. Brock JH (2002) The physiology of lactoferrin. Biochem Cell Biol 80: 1-6.
32. Brody EP (2000) Biological activities of bovine glycomacropeptide. Br J Nutr 84: S39-S46.
33. Brown EM (1984). Interaction of β-lactoglobulin and α-lactalbumin with lipids: a review. J Dairy Sci 67: 713-722.
34. Brown JR, Shockley P (1982) Serum albumin: structure and characterization of its ligand binding sites. In: Lipid Protein Interactions. Jost P, Griffith OH (eds.) New York, John Wiley & Sons.
35. Burke DG, Chilibeck PD, Davidson KS, Candow DG, Farthing J, Smith-Palmer T (2001) The effect of whey protein supplementation with and without creatine monohydrate combined with resistance training on lean tissue mass and muscle strength. Int J Sport Nutr Exerc Metab 11: 349-364.
36. Butler WT (1989) The nature and significance of osteopontin. Connect Tissue Res 23: 123-136.
37. Chambers AF, Behrend EI, Wilson SM, Denhardt DT (1992) Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res 12: 43-47.
38. Chatterton DEW, Rasmussen JT, Heegaard CW, Sorensen ES, Petersen TE (2004) In vitro digestion of novel milk protein ingredients for use in infant formulas: research on biological functions. Trends Food Sci Tech 15: 373-383.
39. Chatterton DEW, Smithers G, Roupas P, Brodkorb A (2006) Bioactivity of β-lactoglobulin and α-lactalbumin-technological implications for processing. Int Dairy J 16: 1229-1240.
40. Cho Y, Batt CA, Sawyer L (1994) Probing the retinol-binding site of bovine b -lactoglobulin. J Biol Chem 269: 11102-11107.
41. Choi JK, Ho J, Curry S, Qin D, Bittman R, Hamilton JA (2002) Interactions of very long-chain saturated fatty acids with serum albumin. J Lipid Res 43: 1000-1010.
42. Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sorensen ES (2005) Posttranslationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem J 390: 285-292.
43. Clare DA, Catignani GL, Swaisgood HE (2003) Biodefense properties of milk, the role of antimicrobial proteins and peptides. Curr Pharm Design 9: 1239-1255.
44. Cornish J, Callon KE, Naot D, Palmano KP, Banovic T, Bava U, Watson M, Lin J-M, Tong PC, Chen Q, Chan VA, Reid HE, Fazzalari N, Baker HM, Baker EN, Haggarty NW, Grey AB, Reid IR (2004) Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145: 4366-4374.
45. Cross ML, Gill HS (1999) Modulation of immune function by a modified bovine whey protein concentrate. Immunol Cell Biol 77: 345-350.
46. Crouch SP, Slater KJ, Fletcher J (1992) Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80: 235-240.
47. Daenzer M, Petzke KJ, Bequette BJ, Metges CC (2001) Whole-body nitrogen and splanchnic amino acid metabolism differ in rats fed mixed diets containing casein or its corresponding amino acid mixture. J Nutr 131: 1965-1972.
48. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y (1999) Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 74: 486-498.
49. Damiens E, Mazurier J, El Yazidi I, Masson M, Duthille I, Spik G, Boilly-Marer Y (1998) Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim Biophys Acta 1402: 277-287.
50. De Wit JN (1989) Functional properties of whey proteins. In: Developments of Dairy Chemistry. Fox PF (ed.). London, Applied Science, vol 4.
51. De Wit JN (1998) Nutritional and functional characteristics of whey proteins in food products. J Dairy Sci 81: 597-602.
52. De Wit JN, van Hooydonk ACM (1996) Structure, functions and applications of lactoperoxidase in natural antimicrobial systems. Neth Milk Dairy J 50: 227-244.
53. Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodelling. J Cell Biochem Suppl 30-31: 92-102.
54. Devlieghere F, Vermeiren L, Debevere J (2004) New preservation technologies: possibilities and limitations. Int Dairy J 14: 273-285.
55. Dhennin-Duthille I, Masson M, Damiens E, Fillebeen C, Spik G, Mazurier J (2000) Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen activated protein kinase in the human lymphoblastic T Jurkat cell line. J Cell Biochem 79: 583-593.
56. Di Mario F, Aragona G, Dal Bo N, Cavestro GM, Cavallaro L, Iori V, Comparato G, Leandro G, Pilotto A, Franze A (2003) Use of bovine lactoferrin for Helicobacter pylori eradication. Dig Liver Dis 35: 706-710.
57. Doyle ME, Mazzotta AS (2000) Review of studies on the thermal resistance of salmonellae. J Food Protect 63: 779-795.
58. Early EM, Hardy H, Forde T, Kane M (2001) Bactericidal effects of a whey protein concentrate with anti-Heliobacter activity. J Appl Microbiol 90: 741-748.
59. El-Fakharany EM, Tabll A, El-Wahab AA, Haroun BM, Redwan E-RM (2008) Potential activity of camel milk-amylase and lactoferrin against hepatitis C virus infectivity in HepG2 and lymphocytes. Hepatitis Mont 8: 101-109.
60. Ellison RT, Giehl TJ (1991) Killing of Gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 88: 1080-1091.
61. Etienne L, Girardet JM, Linden G (1994) Growth promotion of Bifidobacterium animalis by bovine milk protease-peptone. Lait 74: 313-323.
62. Evans EW (1982). Uses of milk proteins in formulated foods. In: Developments in Food Proteins. Hudson BJF (ed.) London: Applied Science, London.
63. Farnaud S, Evans RW (2003) Lactoferrin-a multifunctional protein with antimicrobial properties. Mol Immunol 40: 395-405.
64. Farrell HM, Bede MJ, Enyeart JA (1987) Binding of p-nitrophenyl phosphate and other aromatic compounds by β-LG. J Dairy Sci 70: 252-258.
65. Farrell HM, Jimenez-Flores R, Bleck T, Brown EM, Butler JE, Creamer LK, Hicks CL, Hollar CM, Ng-Kwai-Hang KF, Swaisgood HE (2004) Nomenclature of proteins of cow's milk: sixth revision. J Dairy Sci 87: 1641-1674.
66. Fischer R, Debbabi H, Dubarry M, Boyaka P, Tome D (2006) Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochem Cell Biol 84: 303-311.
67. Fox PF (1989) The milk protein system. In: Developments of Dairy Chemistry. Fox PF (Ed.). London, Applied Science, vol 4.
68. Frydecka I, Zimecki M, Bocko D, Kosmaczewska A, Teodorowska R, Ciszak L, Kruzel M, Wlodarska-Polinska J, Kuliczkowski K, Kornafel J (2002) Lactoferrin-induced upregulation of zeta chain expression in peripheral blood T lymphocytes from cervical cancer patients. Anticancer Res 22: 1897-1901.
69. Fujita K, Ohnishi T, Sekine K, Iigo M, Tsuda H (2002) Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats. Jpn J Cancer Res 93: 616-625.
70. Futterman S, Heller J (1972) The enhancement of fluorescence and the decreased susceptibility to enzymatic oxidation of retinol complexed with bovine serum albumin, β-lactoglobulin and the retinol binding protein of human plasma. J Biol Chem 247: 5168-5172.
71. Ganjam LS, Thornton WH, Marshall RT, MacDonald RS (1997) Antiproliferative effects of yoghurt fractions obtained by membrane dialysis on cultured mammalian intestinal cells. J Dairy Sci 80: 2325-2339.
72. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M (1998) Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152: 353-358.
73. Giachelli CM, Steitz S (2000) Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 19: 615-622.
74. Giansanti F, Rossi P, Massucci MT, Botti D, Antonini G, Valenti P, Seganti L (2002) Antiviral activity of ovotransferrin discloses an evolutionary strategy for the defensive activities of lactoferrin. Biochem Cell Biol 80: 125-130.
75. Gill HS, Cross ML (2000) Anticancer properties of bovine milk. Br J Bovine Milk 84: 161-165.
76. Gill HS, Rutherford KJ, Cross ML (2000) Bovine milk: a unique source of immunomodulatory ingredients for functional foods. In: Functional Foods II-Claims and Evidence. Buttriss J, Saltmarsh M (ed.). Cambridge, England, Royal Society of Chemistry Press, pp. 82-90.
77. Girardet J, Linden G (1996) PP3 component of bovine milk: a phosphorylated whey glycoprotein. J Dairy Res 63: 333-350.
78. Giuffre G, Arena F, Scarfi R, Simone A, Todaro P, Tuccari G (2006) Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival. Oncology Rep 16: 257-263.
79. Goldberg HA, Hunter GK (1995) The inhibitory activity of osteopontin on hydroxyapatite formation in vitro. Ann N Y Acad Sci 760: 305-308.
80. Gomez HF, Ochoa TJ, Herrera-Insua I, Carlin LG, Cleary TG (2002) Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis. Infect Immunity 70: 7050-7053.
81. Goretzki L, Mueller BM (1998) Low-density-lipoprotein receptor-related protein (LRP) interacts with a GTP-binding protein. Biochem J 336: 381-386.
82. Grenby TH, Andrews AT, Mistry M, Williams RJH (2001) Dental caries-protective agents in milk and milk products: investigations in vitro. J Dentistry 29: 83-92.
83. Grey V, Mohammed SR, Smountas AA, Bahlool R, Lands LC (2003) Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cystic Fib 2: 195-198.
84. Guimont C, Marchall E, Girardet JM, Linden G (1997) Biologically active factors in bovine milk and dairy byproducts: influence on cell culture. Crit Rev Food Sci Nutr 37: 393-410.
85. Ha E, Zemel MB (2003) Functional properties of whey, whey components, and essential amino acids: mechanisms underlying health benefits for active people (review). J Nutr Biochem 14: 251-258.
86. Håkansson A, Zhivotovski B, Orrenius S, Sabharwal H, Svanborg C (1995) Apoptosis induced by a human milk protein. Proc Acad Sci USA, 92: 8064-8068.
87. Hall WL, Millward DJ, Long SJ, Morgan LM (2003) Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 89: 339-348.
88. Hangoc G, Falkenburg JHF, Broxmeyer HE (1991) Influence of T-lymphocytes and lactoferrin on the survival-promoting effects of IL-1 and IL-6 on human bone marrow granulocytemacrophage and erythroid progenitor cells. Exp Hematol 19: 697-703.
89. Heuvelink AE, Bleumink B, van den Biggelaar FLAM, Te-Giffel MC, Beumer RR, de Boer E (1998) Occurrence and survival of verocytotoxin-producing Escherichia coli O157 in raw cow's milk in The Netherlands. J Food Protect 61: 1597-1601.
90. Hoerr RA, Bostwick EF (2000) Bioactive proteins and probiotic bacteria: modulators of nutritional health. Nutrition 16: 711-713.
91. Horton BS (1995) Commercial utilization of minor milk components in the health and food industries. J Dairy Sci 78: 2584-2589.
92. Huffman LM, Harper WJ (1999) Maximizing the value of milk through separation technologies. J Dairy Sci 82: 2238-2244.
93. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA (1996) Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317: 59-64.
94. Hunter GK, Kyle CL, Goldberg HA (1994) Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J 300: 723-728.
95. Iigo M, Kuhara T, Uchida Y, Sekine K, Moore MA, Tsuda H (1999) Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis 17: 35-40.
96. Ikeda M, Nozaki A, Sugiyama K, Tanaka T, Naganuma A, Tanaka K, Sekihara H, Shimotohno K, Saito M, Kato N (2000) Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Res 66: 51-63.
97. Innocente N, Corradini C, Blecker C, Paquot M (1999) Emulsifying properties of the total fraction and the hydrophobic fraction of bovine milk proteose-peptones. Int Dairy J 8: 981-985.
98. Iwasa M, Kaito M, Ikoma J, Takeo M, Imoto I, Adachi Y, Yamauchi K, Koizum R, Teraguchi S (2002) Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HGV genotype 1b. Am J Gastroenterol 97: 766-767.
99. Iyer S, Lönnerdal B (1993) Lactoferrin, lactoferrin receptors and iron metabolism. Eur J Clin Nutr 47: 232-241.
100. Joslin RS, Erickson PS, Santoro HM, Whitehouse NL, Schwab CG, Rejman JJ (2002) Lactoferrin supplementation to dairy calves. J Dairy Sci 85: 1237-1242.
101. Kajikawa M, Ohta T, Takase M, Kawase K, Shimamura S, Matsuda I (1994) Lactoferrin inhibits cholesterol accumulation in macrophages mediated by acetylated or oxidized lowdensity lipoproteins. Biochim Biophys Acta 1213: 82-90.
102. Katsuaki T 2006. Functionalities and usefulness of lactoferrins (2) Clinical application of lactoferrin for the treatment of chronic hepatitis C. Foods & Food Ingred J Jpn 211: 748-753.
103. Kawakami A, Hirayama K, Kawakami F, Kawakami H, Fujihara M, Ohtsuki K (2006) Purification and biochemical characterization of fibroblast growth factor-binding protein (FGF-BP) from the lactoferrin fraction of bovine milk. Biochim Biophys Acta 1760: 421-431.
104. Kelly G (2003) Bovine colostrums: a review of clinical uses. Altern Med Rev 8: 378-394.
105. Kennedy RS, Konok GP, Bounous G, Baruchel S, Leet DG (1995) The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical trial study. Anticancer Res 15: 2643-2649.
106. Kent KD, Harper WJ, Bomser JA (2003) Effect of whey protein isolate on intracellular glutathione and oxidant-induced cell death in human prostate epithelial cells. Toxicol In Vitro 17: 27-33.
107. Kim CW, Son K-N, Choi S-Y, Kim J (2006) Human lactoferrin upregulates expression of KDR/Flk-1 and stimulates VEGF-A-mediated endothelial cell proliferation and migration. FEBS Lett 580: 4332-4336.
108. Kinsella JE, Whitehead DM, Brady J, Bringe NA (1989) Milk proteins, possible relationships of structure and function. In: Developments of Dairy Chemistry. Fox PF (ed.). London, Applied Science, vol 4.
109. Konishi M, Iwasa M, Yamauchi K, Sugimoto R, Fujita N, Kobayashi Y, Watanabe S, Teraguchi S, Adachi Y, Kaito M (2006) Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C. Hepatology Res 36: 27-32.
110. Korhonen HJ (2006) Technological and health aspects of bioactive components of milk. Int Dairy J 16: 1227-1228.
111. Kruzel ML, Bacsi A, Choudhury B, Sur S, Boldogh I (2006) Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology 119: 159-166.
112. Kuhara T, Iigo M, Itoh T, Ushida Y, Sekine K, Terada N, Okamura H, Tsuda H (2000) Orally administered lactoferrin exerts an anti metastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr Cancer 38: 192-199.
113. Kuhara T, Yamauchi K, Tamura Y, Okamura H (2006) Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine. J Interferon Cytokine Res 26: 489-499.
114. Kulczycki A Jr, MacDermott RP (1985) Bovine IgG and human immune responses: con A-induced mitogenesis of human mononuclear cells is suppressed by bovine IgG. Int Arch Allergy Appl Immunol 77: 255-258.
115. Kussendrager KD, van Hooijdonk AC (2000) Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications. Br J Nutr 84: S19-S25.
116. Lands LC, Grey VL, Smountas AA (1999) Effect of supplementation with a cysteine donor on muscular performance. J Appl Physiol 87:1381-1385.
117. Larkins N (2005) Potential implications of lactoferrin as a therapeutic agent. Am J Vet Res 66: 739-742.
118. Laursen I, Briand P, Lykkesfeldt AE (1990) Serum albumin as a modulator of the human breast cancer cell line MCF-7. Anticancer Res 10: 343-352.
119. Lee HY, Park JH, Seok SH, Back MW, Kim DJ, Lee BH, Kang PD, Kim YS, Park JH (2005) Potential antimicrobial effects of human lactoferrin against oral infection with Listeria monocytogenes in mice. J Med Microbiol 54: 1049-1054.
120. Legrand D, Elass E, Carpentier M, Mazurier J (2005) Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 62: 2549-2559.
121. Levay PF, Viljoen M (1995) Lactoferrin: a general review. Haematologica 80: 252-267.
122. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL (1998) Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 101: 1468-1478.
123. Loimaranta V, Laine M, Söderling E, Vasara E, Rokka S, Marnila P, Korhonen H, Tossavainen O, Tenovuo J (1999) Effects of bovine immune and non-immune whey preparations on the composition and pH response of human dental plaque. Eur J Oral Sci 107: 244-250.
124. Longhi G, Pietropaolo V, Mischitelli M, Longhi C, Conte MP, Marchetti M, Tinari A, Valenti P, Degener AM, Seganti L, Superti F (2006) Lactoferrin inhibits early steps of human BK polyomavirus infection. Antiviral Res 72: 145-152.
125. Machnicki M, Zimecki M, Zagulski T (1993) Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int J Exp Pathol 74: 433-439.
126. Madureira AR, Pereira CI, Gomes AMP, Pintado ME, Malcata FX (2007) Bovine whey proteins: overview on their main biological properties. Food Res Int 40: 1197-1211.
127. Markus CR, Olivier B, de Haan EH (2002) Whey protein rich in α-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. Am J Clin Nutr 75: 1051-1056.
128. Marshall K (2004) Therapeutic applications of whey. Alt Med Rev 9(2): 136-156.
129. Masuda C, Wanibuchi H, Sekine K, Yano Y, Otani S, Kishimoto T, Tsuda H, Fukushima S (2000) Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis. Jpn J Cancer Res 91: 582-588.
130. Matin MA, Otani H (2000) Release of cytotoxic glycopeptides from human acid casein fraction by the action of stomach proteinases. Michwisenschaft 55: 6-10.
131. McKeown ST, Lundy FT, Nelson J, Lockhart D, Irwin CR, Cowan CG, Marley JJ (2006) The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro. Oral Oncology 42: 685-690.
132. Mehra R, Marnila P, Korhonen H (2006) Milk immunoglobulins for health promotion. Int Dairy J 16: 1262-1271.
133. Mercier A, Gauthier SF, Fliss I (2004) Immunomodulating effects of whey proteins and their enzymatic digests. Int Dairy J 14: 175-183.
134. Micke P, Beeh KM, Buhl R (2002) Effects of long-term supplementation with whey proteins on plasma GSH levels of HIV infected patients. Eur J Nutr 41: 12-18.
135. Micke P, Beeh KM, Schlaak JF, Buhl R (2001) Oral supplementation with whey proteins increases plasma GSH levels of HIV-infected patients. Eur J Clin Inv 31: 171-178.
136. Middleton N, Reid JR, Coolbear T, Jelen P (2003) Proliferation and intracellular gluthathione in Jukart T cells with concentrated whey protein products. Int Dairy J 13: 565-573.
137. Min S, Krochta J (2005) Inhibition of Penicillium commune by edible whey protein films incorporating lactoferrin, lactoferrin hydrolysate, and lactoperoxidase systems. J Food Sci 70: 87-94.
138. Mistry N, Drobni P, Naslund J, Sunkari VG, Jenssen H, Evander M (2007) The anti-papillomavirus activity of human and bovine lactoferricin. Antiviral Res 75: 258-265.
139. Miyazawa K, Mantel C, Lu L, Morrison DC, Broxmeyer HE (1991) Lactoferrin lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage differentiated HL-60 cells. J Immunol 146: 723-729.
140. Mohan KV, Devaraj H, Prathiba D, Hara Y, Nagini S (2006) Antiproliferative and apoptosis inducing effect of lactoferrin and black tea polyphenol combination on hamster buccal pouch carcinogenesis. Biochim Biophys Acta 1760: 1536-1544.
141. Nagata T, Bellows CG, Kasugai S, Butler WT, Sodek J (1991) Biosynthesis of bone proteins (SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)) in association with mineralized-tissue formation by fetal-rat calvarial cells in culture. Biochem J 274: 513-520.
142. Naidu A (2002) Activated lactoferrin-a new approach to meat safety. Food Technol 56: 40-45.
143. Nemet K, Simonovits I (1985) The biological role of lactoferrin. Haematologia 18: 3-12.
144. Norrby K, Mattsby-Baltzer I, Innocenti M, Tuneberg S (2001) Orally administrated bovine lactoferrin systematically inhibits VEGF165-mediated angiogenesis in the rat. Int J Cancer 91: 236-240.
145. Nuijens JH, van Berkel PH, Schanbacher FL (1996) Structure and biological actions of lactoferrin. J Mammary Gland Biol Neoplasia 1: 285-295.
146. O'Neil TE, Kinsella JE (1987) Binding of alkanone flavours to β-lactoglobulin, effects of conformational and chemical modification. J Agr Food Chem 35: 770-774.
147. Oevermann A, Engels M, Thomas U, Pellegrini A (2003) The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification. Antiviral Res 59: 23-33.
148. Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass E, DuPont HL (1998) Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostra immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis 26: 1324-1329.
149. Oldberg A, Franzen A, Heinegard D (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83: 8819-8823.
150. Pan Y, Lee A, Wan J, Coventry MJ, Michalski WP, Shielf B, Roginski H (2006) Antiviral properties of milk proteins and peptides. Int Dairy J 16: 1252-1261.
151. Pan Y, Rowney M, Guo P, Hobman P (2007) Biological properties of lactoferrin: an overview. Aust J Dairy Techn 62: 31-42.
152. Parodi PW (1998) A role for milk proteins in cancer prevention. Aust J Dairy Sci 53: 37-47.
153. Patarca R, Freeman GJ, Singh RP, Wei F-Y, Durfee T, Blattner F, Regnier D, Kozak CA, Mock BA, Morse HC, Jerrells TR, Cantor H (1989) Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med 170: 145-161.
154. Patarca R, Saavedra RA, Cantor H (1993) Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol 13: 225-246.
155. Patocka J, Jelen P (1991) Calcium association with isolated whey proteins. Can Inst Food Sci Tech J 24: 218-224.
156. Perez MD, Calvo M (1995) Interaction of β-lactoglobulin with retinol and fatty acids and its role as a possible biological function for this protein. A review. J Dairy Sci 78: 978-988.
157. Perez MD, Sanchez L, Aranda P, Ena JM, Oria R, Calvo M (1992) Effect of β-lactoglobulin on the activity of pregastric lipase. A possible role for this protein in ruminant milk. Biochem Biophys Acta 1123: 151-155.
158. Perraudin JP (1991) Proteines a` activités biologiques, lactoferrin et lactoperoxydase. Connaissances recemment acquises et technologies d'obtention. Le Lait 71: 191-211.
159. Peterson NA, Anderson BF, Jameson GB, Tweedie JW, Baker EN (2000) Crystal structure and iron-binding properties of the R210K mutant of the N-lobe of human lactoferrin: implications for iron release from transferrins. Biochemistry 39: 6625-6633.
160. Prince CW, Oosawa T, Butler WT, Tomana M, Bhown AS, Bhown M, Schrohenloher RE (1987) Isolation, characterization and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem 262: 2900-2907.
161. Puyol P, Pérez MD, Ena JM, Calvo M (1991) Interaction of β-lactoglobulin and other bovine and human whey proteins with retinol and fatty acids. Agr Biol Chem 10: 2515-2520.
162. Qiu J, Hendrixson DR, Baker EN, Murphy TF, St Geme JW, Plaut AG (1998) Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc Natl Acad Sci USA 95: 12641-12646.
163. Reiter B, Harnulv G (1984) Lactoperoxidase antibacterial system, natural occurrence, biological functions and practical applications. J Food Protection 47: 724-732.
164. Reiter B, Perraudin J-P (1991) Lactoperoxidase, biological functions. In: Peroxidases in Chemistry and Biology. Everse J, Everse KE, Grisham MB (Eds.). Boca Raton, FL, CRC Press, vol 1, pp. 144-180.
165. Roberts AK, Chierici R, Sawatzki G, Hill MJ, Volpato S, Vigi V (1992) Supplementation of an adapted formula with bovine lactoferrin: 1. Effect on the infant faecal flora. Acta Paediatr 81: 119-124.
166. Roberts SB, McMcrory MA, Saltzman E (2002) The influence of dietary composition on energy intake and body weight. J Am Col Nutr 21: 140S-145S.
167. Rodrigues LR, Teixeira JA, Schmitt F, Paulsson M, Lindmark Måsson H (2009) Lactoferrin and cancer disease prevention. Crit Rev Food Sci Nut 49: 1-15.
168. Rodrigues LR, Teixeira JA, Schmitt F, Paulsson M, Lindmark-Mansson H (2007) The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomarkers Prev 16: 1087-1097.
169. Rodrigues LR, Venâncio A, Teixeira JA (2003) Recovery of the proteose peptone component 3 from cheese whey in Reppal PES 100/polyethylene glycol aqueous two-phase systems. Biotechnol Lett 25: 651-655.
170. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, Cheresh DA (1993) Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J Biol Chem 268: 9901-9907.
171. Rowlands JC, He Ling, Hakkak R, Ronis MJJ, Badger TM (2001) Soy and whey proteins downregulate DMBA-induced liver and mammary gland CYP1 expression in female rats. J Nutr 131: 3281-3287.
172. Said HM, Ong DE, Shingleton JL (1989) Intestinal uptake of retinol, enhancement by bovine milk β-lactoglobulin. Am J Clin Nutr 49: 690-694.
173. Sanchez L, Calvo M, Brock JH (1992) Biological role of lactoferrin. Arch Dis Child 67:657-661.
174. Santagati MG, La Terra Mulle S, Amico C, Pistone M, Rusciano D, Enea V (2005) Lactoferrin expression by bovine ocullar surface epithelia: a primary cell culture model to study lactoferrin gene promoter activity. Ophthalmic Res 37: 270-278.
175. Santana MA, Rosenstein Y (2003) What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J Cell Physiol 195: 392-401.
176. Sarker SA, Casswall TH, Mahalanabis D, Alam NH, Albert MJ, Brussow H, Fuchs GJ, Hammerstrom L (1998) Successful treatment of rotavirus diarrhoea in children with immunoglobulin from immunised bovine colostra. Pead Infect Dis J 17: 1149-1154.
177. Sekine K, Watanabe E, Nakamura J, Takasuka N, Kim DJ, Asamoto M, Krutovskikh V, Baba-Toriyama H, Ota T, Moore MA, Masuda M, Sugimoto H, Nishino H, Kakizoe T, Tsuda H (1997) Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn J Cancer Res 88: 523-526.
178. Senger DR, Perruzzi CA, Papadopoulos A (1989a) Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res 9: 1291-1299.
179. Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Tenen DG (1989b) Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta 996: 43-48.
180. Senkovich O, Cook WJ, Mirza S, Hollingshead SK, Protasevich II, Brilles DE, Chattopadhyay D (2007) Structure of a complex human lactoferrin N-lobe with pneumococcal surface protein A provides insight into microbial defense mechanism. J Mol Biol 370: 701-713.
181. Sharpe SJ, Gamble GD, Sharpe DN (1994) Cholesterol lowering and blood pressure effects of immune milk. Am J Clin Nutr 59: 929-934.
182. Shimamura M, Yamamoto Y, Ashino H, Oikawa T, Hazato T, Tsuda H, Iigo M (2004) Bovine lactoferrin inhibits tumor induced angiogenesis. Int J Cancer 111: 111-116.
183. Shin K, Tomita M, Lonnerdal B (2000) Identification of lactoperoxidase in mature human milk. J Nutr Biochem 11: 94-102.
184. Siciliano R, Rega B, Marchetti M, Seganti L, Antonini G, Valenti P (1999) Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection. Biochem Biophys Res Comm 264: 19-23.
185. Sitohy M, Dalgalarrondo M, Nowoczin M, Besse B (2000) Release of cytotoxic glycopeptides from human acid casein fraction by the action of stomach proteinases. Michwisenschaft 55: 6-10.
186. Sitohy M, Dalgalarrondo M, Nowoczin M, Besse B, Billaudel S, Haertlé T, Chobert JM (2008) The effect of bovine whey proteins on the ability of poliovirus and Coxsackie virus to infect Vero cell cultures. Int Dairy J 18: 658-668.
187. Slater K, Fletcher J (1987) Lactoferrin derived from neutrophils inhibits the mixed lymphocyte reaction. Blood 69: 1328-1333.
188. Smith LM, Fantozzi P, Creveling RK (1983) Study of triglyceride-protein interaction using a microemulsion filtration method. J Am Oil Chem Soc 60: 960-965.
189. Smithers GW (2008) Whey and whey proteins. Int Dairy J 18: 695-704.
190. Smithers GW, Ballard FJ, Copeland AD, Silva KJ, Dionysius DA, Francis GL, Goddard C, Grieve PA, McIntosh GH, Mitchell IR, Pearce RJ, Regester GO (1996) New opportunities from the isolation and utilization of whey proteins. J Dairy Sci 79: 1454-1459.
191. Sodek J, Ganss B, McKee MD (2000) Osteopontin. Crit Rev Oral Biol Med 11: 279-303.
192. Sorensen ES, Rasmussen LK, Moller L, Petersen TE (1997) The localization and multimeric nature of component PP3 in bovine milk: purification and characterization of PP3 from caprine and ovine milks. J Dairy Sci 80: 3176-3181.
193. Sousa A, Passarinha LA, Rodrigues LR, Teixeira JA, Mendonça A, Queiroz JA (2007) Separation of different forms of PP3 by hydrophobic interaction chromatography with a dual salt system. Biomed Chrom 22: 447-449.
194. Steijns J, van Hooijdonk A (2000) Occurrence, structure, biochemical properties technological characteristics of lactoferrin. Br J Nutr 84: S11-S17.
195. Sternhagen LG, Allen JC (2001) Growth rates of a human colon adenocarcinoma cell line are regulated by the milk protein alpha-lactalbumin. Adv Exp Med Biol 501: 115-120.
196. Sugahara T, Onda H, Shinohara Y, Horii M, Akiyama K, Nakamoto K, Hara K (2005) Immunostimulation effects of proteose-peptone component 3 fragment on human hybridomas and peripheral blood lymphocytes. Biochim Biophys Acta 1725: 233-240.
197. Takada Y, Aoe S, Kumegawa M (1996). Whey protein stimulates cell proliferation and differentiation in osteoblastic MC3T3-E1 cells. Biochem Biophys Res Comm 223: 445-499.
198. Tanaka K, Ikeda M, Nozaki A, Kato N, Tsuda H, Saito S, Sekihara H (1999) Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn J Cancer Res 90: 367-371.
199. Tanaka T, Kawabata K, Kohno H, Honjo S, Murakami M, Ota T, Tsuda H (2000) Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. Jpn J Cancer Res 91: 25-33.
200. Tawa NE Jr, Goldberg AL (1992) Suppression of muscle protein turnover and amino acid degradation by dietary protein deficiency. Am J Physiol 263: E317-E325.
201. Tenovuo J (2002) Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis 8: 23-29.
202. Teraguchi S, Wakabayashi H, Kuwata H, Yamauchi K, Tamura Y (2004) Protection against infections by oral lactoferrin: evaluation in animal models. Biometals 17: 231-234.
203. Thoma-Worringer C, Sorensen J, López-Fandiño R (2006) Health effects and technological features of caseinomacropeptide. Int Dairy J 16: 1324-1333.
204. Tomita M, Wakabayashi H, Yamauchi K, Teraguchi S, Hayasawa H (2002) Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem Cell Biol 80: 109-112.
205. Tong LM, Sasaki S, McClements DJ, Decker EA (2000) Mechanisms of the antioxidant activity of a high molecular weight fraction of whey. J Agr Food Chem 48: 1473-1478.
206. Troost FJ, Steijns J, Saris WHM, Brummer R-J (2001) Gastric digestion of bovine lactoferrin in vivo in adults. J Nutr 131: 2101-2104.
207. Trumpler U, Straub PW, Rosenmund A (1989) Antibacterial prophylaxis with lactoferrin in neutropenic patients. Eur J Clin Microbiol Infect Dis 8: 310-313.
208. Tsai WY, Chang WH, Chen CH, Lu FJ. (2000) Enhancing effect of patented whey protein isolate (Immunocal) on cytotoxicity of an anticancer drug. Nutr Cancer 38: 200-208.
209. Tsuda H, Sekine K, Fujita K, Iigo M (2002) Cancer prevention by bovine lactoferrin and underlying mechanisms-a review of experimental and clinical studies. Biochem Cell Biol 80: 131-136.
210. Tsuda H, Sekine K, Ushida Y, Kuhara T, Takasuka N, Iigo M, Han BS, Moore MA (2000) Milk and dairy products in cancer prevention: focus on bovine lactoferrin. Mutat Res 462: 227-233.
211. Ushida Y, Sekine K, Kuhara T, Takasuka N, Iigo M, Tsuda H (1998) Inhibitory effects of bovine lactoferrin on intestinal polyposis in the ApcMin mouse. Cancer Lett 134: 141-145.
212. Ushida Y, Sekine K, Kuhara T, Takasuka N, Iigo M, Maeda M, Tsuda H (1999) Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat. Jpn J Cancer Res 90: 262-267.
213. Valenti P, Marchetti M, Superti F, Amendolia MG, Puddu P, Gessani S, Borghi P, Belardelli F, Antonini G, Seganti L (1998) Antiviral activity of lactoferrin. Adv Exp Med Biol 443: 199-203.
214. Van Snick JL, Masson PL (1976) The binding of human lactoferrin to mouse peritoneal cells. J Exp Med 144: 1568-1580.
215. Varadhachary A, Wolf JS, Petrak K, O'Malley BW Jr, Spadaro M, Curcio C, Forni G, Pericle F (2004) Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int J Cancer 111: 398-403.
216. Vorland LH (1999) Lactoferrin: a multifunctional glycoprotein. Acta Pathol Microbiol Immunol Scand 107: 971-981.
217. Wakabayashi H, Yamauchi K, Takase M (2006) Lactoferrin research, technology and applications. Int Dairy J 16: 1241-1251.
218. Walzem RL, Dillard CJ, German JB (2002) Whey components: millennia of evolution create functionalities for mammalian nutrition: what we know and what we may be overlooking. Crit Rev Food Sci Nut 42: 353-375.
219. Wang Q, Allen JC, Swaisgood HE (1997) Binding of vitamin D and cholesterol to β-lactoglobulin. J Dairy Sci 80: 1054-1059.
220. Wang WP, Iigo M, Sato J, Sekine K, Adachi I, Tsuda H (2000) Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn J Cancer Res 91: 1022-1027.
221. Ward PP, Paz E, Conneely OM (2005) Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 62: 2540-2548.
222. Warme PKF, Momany A, Rumball SV, Tuttle RW, Scheraga HA (1974) Computation of structures of homologous proteins. α-Lactalbumin from lysozyme. Biochemistry 13: 768-772.
223. Weinberg ED (1996) The role of iron in cancer. Eur J Cancer Prev 5: 19-36.
224. Weinberg ED (2007) Antibiotic properties and applications of lactoferrin. Curr Pharm Design 13: 801-811.
225. Wever R, Kast WM, Kasinoedin JH, Boelend R (1982) The peroxidation of thiocyanate catalysed by myeloperoxidase and lactoperoxidase. Biochim Biophys Acta 709: 212-219.
226. Wong CW, Watson DL (1995) Immunomodulatory effects of dietary whey proteins in mice. J Dairy Res 62: 359-368.
227. Wu S-Y, Pérez MD, Puyol P, Sawyer L (1999) β-Lactoglobulin binds palmitate within its central cavity. J Biol Chem 274: 170-174.
228. Yamauchi K, Tomita M, Giehl TJ, Ellison RT (1993) Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 61: 719-728.
229. Yamauchi K, Wakabayashi H, Shin K, Takase M (2006) Bovine lactoferrin: benefits and mechanism of action against infections. Biochem Cell Biol 84: 291-296.
230. Yoo YC, Watanabe S, Watanabe R, Hata K, Shimazaki K, Azuma I (1997) Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 88: 184-190.
231. Zall RR (1984) Trends in whey fractionation and utilization, a global perspective. J Dairy Sci 67: 2621-2629.
232. Zhang Q, Domenicucci C, Goldberg HA, Wrana JL, Sodek J (1990) Characterization of fetal porcine bone sialoproteins, secreted phosphoprotein I (SPPI, osteopontin), bone sialoprotein, and a 23-kDa glycoprotein. Demonstration that the 23-kDa glycoprotein is derived from the carboxyl terminus of SPPI. J Biol Chem 265: 7583-7589.
233. Zhang X, Beynen AC (1993) Lowering effect of dietary milk-whey protein vs. casein on plasma and liver cholesterol in rats. Br J Nutr 70: 139-146.
234. Zimecki M, Mazurier J, Machnicki M, Wieczorek Z, Montreuil J, Spik G (1991) Immunostimulatory activity of lactotransferrin and maturation of CD4-CD8-murine thymocytes. Immunol Lett 30: 119-123.
235. Zimecki M, Mazurier J, Spik G, Kapp JA (1995) Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology 86: 122-127.
236. Zydney AL (1998) Protein separations using membrane filtration: new opportunities for whey fractionation. Int Dairy J 8: 243-250.